We found that the expression of ITPR1 gene is unstable in head and neck cancer, kidney cancer, leukemia, melanoma and sarcoma, but in bladder cancer, brain and central nervous system cancer, breast cancer, cervical cancer, colorectal cancer, lung cancer, lymphoma, Ovarian cancer and prostate cancer had lower expression (Fig. 1A). This evidence concerns the gene ITPR1 and prostate cancer.